Financiere des Professionnels Fonds d investissement inc. Has $2.84 Million Stake in UnitedHealth Group Incorporated $UNH

Financiere des Professionnels Fonds d investissement inc. increased its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 1,309.4% in the first quarter, Holdings Channel.com reports. The firm owned 10,500 shares of the healthcare conglomerate’s stock after purchasing an additional 9,755 shares during the quarter. Financiere des Professionnels Fonds d investissement inc.’s holdings in UnitedHealth Group were worth $2,841,000 as of its most recent SEC filing.

Other hedge funds have also modified their holdings of the company. Sarver Vrooman Wealth Advisors bought a new stake in UnitedHealth Group in the 4th quarter valued at approximately $25,000. Beacon Financial Strategies CORP acquired a new stake in shares of UnitedHealth Group in the fourth quarter valued at approximately $26,000. Anfield Capital Management LLC lifted its position in shares of UnitedHealth Group by 220.0% in the fourth quarter. Anfield Capital Management LLC now owns 80 shares of the healthcare conglomerate’s stock worth $26,000 after purchasing an additional 55 shares in the last quarter. Joseph Group Capital Management bought a new position in UnitedHealth Group in the fourth quarter valued at $27,000. Finally, Nalls Sherbakoff Group LLC bought a new stake in UnitedHealth Group during the 4th quarter worth about $27,000. 87.86% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In other UnitedHealth Group news, CEO Patrick Hugh Conway sold 800 shares of the company’s stock in a transaction on Thursday, April 23rd. The stock was sold at an average price of $355.00, for a total value of $284,000.00. Following the transaction, the chief executive officer directly owned 17,805 shares of the company’s stock, valued at $6,320,775. This represents a 4.30% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. 0.28% of the stock is currently owned by corporate insiders.

UnitedHealth Group Price Performance

Shares of UNH opened at $423.27 on Friday. The firm has a market capitalization of $384.39 billion, a PE ratio of 31.97, a PEG ratio of 1.68 and a beta of 0.62. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.80 and a quick ratio of 0.80. The company’s 50-day moving average is $403.87 and its 200-day moving average is $341.69. UnitedHealth Group Incorporated has a fifty-two week low of $234.60 and a fifty-two week high of $461.62.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Thursday, July 16th. The healthcare conglomerate reported $6.38 EPS for the quarter, beating analysts’ consensus estimates of $4.87 by $1.51. The business had revenue of $112.03 billion for the quarter, compared to analyst estimates of $110.81 billion. UnitedHealth Group had a net margin of 2.68% and a return on equity of 14.65%. UnitedHealth Group’s quarterly revenue was up .4% on a year-over-year basis. During the same quarter in the prior year, the business earned $4.08 EPS. UnitedHealth Group has set its FY 2026 guidance at 19.500-20.000 EPS. Equities analysts forecast that UnitedHealth Group Incorporated will post 18.39 EPS for the current year.

UnitedHealth Group Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, June 23rd. Investors of record on Monday, June 15th were issued a dividend of $2.32 per share. This represents a $9.28 annualized dividend and a yield of 2.2%. The ex-dividend date of this dividend was Monday, June 15th. This is an increase from UnitedHealth Group’s previous quarterly dividend of $2.21. UnitedHealth Group’s payout ratio is 70.09%.

UnitedHealth Group News Summary

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: UnitedHealth beat Q2 expectations on both earnings and revenue, with EPS of $6.38 versus estimates around $4.87-$4.94 and revenue of $112.03 billion topping forecasts. UnitedHealth Group Inc (UNH) Q2 2026 Earnings Call Highlights: Strong EPS Growth Amidst Cost …
• Positive Sentiment: The company lifted its 2026 adjusted EPS guidance to $19.50-$20.00, above prior expectations, signaling improved confidence in profitability and operating execution. UnitedHealth raises 2026 forecast as it controls medical costs
• Positive Sentiment: Lower medical costs and stronger performance in Optum helped margins, suggesting UnitedHealth is better controlling expenses than investors feared. UnitedHealth blows past estimates, hikes earnings outlook as it reins in costs
• Positive Sentiment: Several analyst notes turned more constructive after the report, including upgrades and higher price targets, which can add to momentum around the stock. Benzinga analyst update
• Neutral Sentiment: Broader market weakness did not stop the move, indicating UNH’s gains were driven mainly by company-specific results rather than the overall tape. Update: Wall Street Snaps Two-Day Advance as Chip-Related Stocks Slump

Analyst Upgrades and Downgrades

Several brokerages have recently weighed in on UNH. KeyCorp raised their price objective on UnitedHealth Group from $400.00 to $475.00 and gave the company an “overweight” rating in a report on Tuesday. JPMorgan Chase & Co. raised their price target on UnitedHealth Group from $420.00 to $466.00 and gave the company an “overweight” rating in a research note on Monday, June 8th. Barclays upped their price objective on UnitedHealth Group from $373.00 to $429.00 and gave the stock an “overweight” rating in a research note on Tuesday, May 26th. TD Cowen boosted their target price on shares of UnitedHealth Group from $337.00 to $430.00 and gave the stock a “hold” rating in a report on Tuesday. Finally, Royal Bank Of Canada increased their price target on shares of UnitedHealth Group from $400.00 to $463.00 and gave the company an “outperform” rating in a research note on Thursday, July 9th. Two analysts have rated the stock with a Strong Buy rating, twenty have given a Buy rating and five have given a Hold rating to the company’s stock. According to MarketBeat, UnitedHealth Group currently has an average rating of “Moderate Buy” and an average target price of $438.92.

UnitedHealth Group Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.